Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 10Sarcoma 3Gastrointestinal 3Thoracic 2Head & Neck 2CNS 2Breast 2NET 1Lymphoid 1Gynecologic 1Genitourinary 1Endocrine 1

Conditions

Ovarian Neoplasms 96Carcinoma, Ovarian Epithelial 31Fallopian Tube Neoplasms 28Breast Neoplasms 25Carcinoma, Non-Small-Cell Lung 21Melanoma 20Uterine Cervical Neoplasms 16Pancreatic Neoplasms 14Neoplasm Metastasis 13Colorectal Neoplasms 13Stomach Neoplasms 11Triple Negative Breast Neoplasms 10Carcinoma, Hepatocellular 10Sarcoma 9Lung Neoplasms 9Head and Neck Neoplasms 9Recurrence 8Neoplasms 8Anus Neoplasms 8Multiple Myeloma 7Esophageal Neoplasms 7Sarcoma, Synovial 6Neuroblastoma 6Carcinoma, Renal Cell 6Vaginal Neoplasms 5Urinary Bladder Neoplasms 5Testicular Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Penile Neoplasms 5Lymphoma, Non-Hodgkin 5

Interventions

utomilumab 1tislelizumab 1spartalizumab 1entinostat 1cemiplimab 1Thrombopoietin 1Polyethylene Glycols 1Nivolumab 1Immunologic Techniques 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Cyclophosphamide 1Carboplatin 1Bevacizumab 1ADI PEG20 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uveal Melanoma × Cyclophosphamide × Gynecologic × Clear all
NCT05075993 2025-12-26

Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
352 enrolled
DermatologicGastrointestinalGynecologicSarcoma

Uveal Melanoma, Carcinoma, Hepatocellular, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡